A little-known biotech company has filed a patent on what medical insiders are already calling, “an enormous scientific breakthrough” and “the biggest medical advancement in 50 years.” This treatment is currently in Phase 3 clinical trials – the final stage before government approval -- and can help eradicate a disease which claims 8.2 million lives every year. America’s top doctors are saying, “there’s an urgent unmet need for this.” InvestorPlace’s FDA approval expert, Matt McCall, is revealing his full analysis on why the stock behind this new treatment could soar as we grow closer to FDA review…
January 24, 2019
Don’t forget! TONIGHT is the 2019 Blockbuster FDA Approval Summit. I’m revealing what Business Insider is calling “the most valuable substance in the world” and how a little-known company that filed a patent on it could become frontpage news just weeks from now. Check your inbox for a link to the event.
January 22, 2019
What’s underneath this linen cover is alive…and is the reason a $100 billion drug market could soon be turned upside down. I’m revealing exactly what’s inside this tank, and why it has major implications for your health and wealth in 2019. Be sure to watch the FDA Approval Summit, it’s coming soon!
January 18, 2019
Big news… Adam Johnson just signed on to host the 2019 Blockbuster FDA Approval Summit. Adam is a financial journalist who worked for Bloomberg Television and has interviewed the top investors of all time, like Wilbur Ross, Carl Icahn, and Sam Zell. Looking forward to hearing Adam’s thoughts on this Phase 3 breakthrough!
January 7, 2019
InvestorPlace just booked the studio for the Blockbuster FDA Approval Summit. It’s just days from now. Scientists are saying this is “the biggest advancement in 50 years” and “an enormous scientific breakthrough.” The tiny firm I’ve been following could easily become the next Pfizer or Merck. Stay tuned for more…
November 26, 2018
Wow! A tiny, $7 million firm is at the forefront of this Phase 3 breakthrough. It’s being called the biggest medical advancement in decades. Even with conservative pricing, revenue could grow 12,042% from here. Digging into this special situation… we’ll have the full story for you very soon. More to come…
November 19, 2018
Just stumbled across a major biotechnology breakthrough, which scientists have uncovered in the unlikeliest of places. Seriously, if it were found buried beneath the White House it would probably be LESS surprising. One tablespoon of this stuff is worth $152,343 and could save 8.2 million lives annually. This is BIG. Stay tuned for more…
Matt McCall manages the wealth of America’s richest individuals through his investment advisory firm, Penn Financial. In the past, Matt worked as a high-powered broker for investment bank Charles Schwabb, and he launched his own early-stage equity funding firm which led to major IPOs. Matt co-hosted a daily investment show on Fox Business Network and he’s appeared regularly on Bloomberg TV and CNN to share his investment insights.
InvestorPlace is hosting the first-ever Blockbuster FDA Approval Summit.
The goal of this event is to uncover the next major scientific breakthrough which could unleash triple or even quadruple-digit gains in the stock market.
We’re tracking the same type of special situation which led to Celgene growing 5,387%, United Therapeutics rising 4,201%, and Medivation Inc. soaring 15,868%.
But the drug Matt McCall has pinpointed could be even bigger, because there’s 15.5 million people who need it right now. Doctors, scientists and patients the world over are eagerly awaiting its approval.
This breakthrough could be the biggest lifesaving treatment of the past 50 years, while simultaneously helping early investors get rich, starting with very little money.
Tune in to the Blockbuster FDA Approval Summit to discover all the details…